Preferred Name |
candesartan |
|
Synonyms |
2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-benzimidazole-7-carboxylic acid CV-11974 2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole CV 11974 CV11974 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C081643 |
|
altLabel |
2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-benzimidazole-7-carboxylic acid CV-11974 2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole CV 11974 CV11974 |
|
cui |
C0717550 C0217087 |
|
HM |
D013777 D001713 D001562 |
|
Inverse of RB |
S8Q36MD2XX |
|
isa | ||
Mapped to |
http://purl.bioontology.org/ontology/MESH/D001713 |
|
MDA |
19930712 |
|
MeSH Frequency |
1884 |
|
MMR |
20210218 |
|
notation |
C081643 |
|
PA |
D000959 D047228 |
|
prefLabel |
candesartan |
|
RR |
139481-59-7 (candesartan) |
|
SC |
1 |
|
Scope Statement |
a nonpeptide angiotensin II receptor antagonist |
|
SRC |
Eur J Pharmacol 1993 Apr 28;235(2-3):313-6 |
|
TERMUI |
T247711 T247713 T247710 T247714 T001097707 T247712 |
|
TH |
NLM (1993) FDA SRS (2013) USAN (1993) NLM (2021) INN (1993) |
|
tui |
T109 T121 |